research_lead_image2.png

Clinical Research

Clinical Research

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. Clinical research includes trials that test new treatments and therapies, genetic studies to explore ways in which a person’s genes may contribute to developing a disorder and epidemiological studies to understand the patterns, causes, and effects of health and disease. 

The Alopecia Areata Registry, Biobank and Clinical Trials Network (Registry) collects research samples that will help determine the genetic components of alopecia areata and help researchers develop new treatments, diagnostic tools and prevention measures. Participants in the Registry may also be solicited for clinical trials of any new therapies for alopecia areata. If you would like to help, please join the Registry and add to our nearly 10,000 registrants.

Clinical Trials

Human clinical trials are a critical phase to bringing safe and effective treatments to market. Many tests are conducted before the clinical trial stage to determine whether potential treatments are appropriate for testing in people. It is through clinical trials that safe and effective drugs, therapies and ultimately, a cure for alopecia areata will be discovered. By participating in a clinical trial, you play an important role in the fight to treat and cure alopecia areata. The decision to participate, however, is very personal and should be made only after speaking with your health care provider and other individuals you trust. You can stop participation in a clinical trial at any time if new concerns arise or you lose confidence that its potential benefits outweigh its risks.

Clinical Trial Resources

ClinicalTrials.gov offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions. Visit ClinicalTrials.gov to review clinical trials that are enrolling around the country on alopecia areata and other diseases.

Clinical Trials and Research Studies

The National Alopecia Areata Foundation is committed to delivering accurate and reliable information to everyone affected by alopecia areata, and subsequently reviews many requests for participation in research studies. The following is a current list of other research studies seeking to recruit people with alopecia areata. 

Disclaimer: NAAF provides research notices as an informational service to its members. NAAF is not conducting the study. This information does not represent a NAAF endorsement, but rather makes you aware that clinical studies are available for your participation if you choose. If you are presently under the care of a physician for alopecia areata, or other conditions, you should discuss this study with your doctor before altering your treatment program. NAAF is not responsible for any adverse outcomes.

The following research centers are looking for volunteers to participate in a research study that will use an investigational topical product for alopecia areata. 

ActivMed Practices & Research, Beverly, Massachusetts 
Click here to learn more.

University of Minnesota, Minneapolis, Minnesota
Click here to learn more. 

La Jolla Institute for Allergy and Immunology, La Jolla, CA
La Jolla Instistute for Allergy and Immunology is seeking volunteers to provide a standard blood donation for a research study to better understand the immune response in alopecia areata. Click here to learn more.

Icahn School of Medicine at Mount Sinai, New York, NY
Ichan School of Medicine at Mount Sinai is seeking volunteers for a study evaluating the effectiveness of a new study drug in the treatment of moderate to severe alopecia areata. Click here to learn more.

Texas Woman’s University, Denton, TX
A doctoral student at is conducting voluntary confidential interviews to explore the experiences of family members of persons diagnosed with alopecia areata. The desired results of this study will aid family therapists and other professionals to better help those living with alopecia areata, as well as their families. Click here to learn more.

University of Minnesota, Minneapolis, MN
New York Presbyterian Hospital, Columbia University, New York, NY
Intralesional steroids are the most commonly used treatment for alopecia areata, yet much remains unknown about the risks and benefits of different doses of intralesional steroids. The goal of this study is to answer some of those questions. This study is currently recruiting participants. Click here to learn more.

New York Presbyterian Hospital, Columbia University, New York, NY
Many people in the U.S. suffer from alopecia areata, yet treatment options are limited and sometimes painful. The goal of this study is to test a medication, given as a subcutaneous injection that acts on the immune system and may reverse hair loss. Enrollment for this study has been completed. This study is ongoing but no longer recruiting participants. Click here to learn more.

New York Presbyterian Hospital, Columbia University, New York, NY
Many people in the U.S. suffer from alopecia areata, yet treatment options are limited and sometimes painful. The goal of this study is to test a new medication taken as a pill that acts on the immune system and may reverse hair loss. Enrollment for this study has been completed. Click here to learn more.

Type 1 Diabetes TrialNet (TrialNet) is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes. Alopecia Areata families have a higher incidence of other autoimmune diseases, including type 1 diabetes (T1D). Relatives of someone with T1D have 15 to 20 times the risk to develop the disease. TrialNet is offering T1D risk screening to blood relatives of someone with T1D through a blood test performed at no cost and available anywhere in the US. Click here to learn more.